0001437749-24-018802.txt : 20240530
0001437749-24-018802.hdr.sgml : 20240530
20240530213133
ACCESSION NUMBER: 0001437749-24-018802
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240528
FILED AS OF DATE: 20240530
DATE AS OF CHANGE: 20240530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Garlikov Julie
CENTRAL INDEX KEY: 0001793266
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33678
FILM NUMBER: 241007366
MAIL ADDRESS:
STREET 1: 2420 17TH STREET
STREET 2: SUITE 220
CITY: DENVER
STATE: CO
ZIP: 80202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001389545
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 680454536
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 899-8800
MAIL ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-05-28
0001389545
NovaBay Pharmaceuticals, Inc.
NBY
0001793266
Garlikov Julie
C/O NOVABAY PHARMACEUTICALS, INC.
2000 POWELL STREET, SUITE 1150
EMERYVILLE
CA
94608
1
0
Restricted Stock Units
2024-05-28
4
A
0
30000
0
A
Common Stock
30000
30000
D
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. The number of restricted stock units and related contingent right to receive common stock does not give effect to the 1-for-35 reverse stock split the issuer effected on May 30, 2024.
/s/ Justin Hall as attorney in fact for Julie Garlikov
2024-05-30